Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Hockey India on Monday announced the 20-member squad for the Men's Junior Asia Cup, a qual
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
Pfizer vaccine less effective against South African variant: Study Last Updated : 24 Mar 2021 03:45:14 AM IST The Pfizer-BioNTech Covid-19 vaccine is moderately less effective against the South African variant, suggests a study.
The findings, published in the journal Cell Host & Microbe, showed that the vaccine is effective against the original SARS-CoV-2 strain and the UK variant, but provides weakened protection against the South African variant and the combined UK-South African variants."Our findings show that future variants could necessitate a modified vaccine as the virus mutates to increase its infectivity," said researcher Ran Taubea from the Ben-Gurion University of the Negev in Israel.For the study, the research team looked at the effectiveness of the vaccine against the original viral strain, the UK and the South African variants, as well as strains that harbour combined changes in the viral spike.They are continuing to test other circulating variants as they constantly emerge with the hope to identify potentially risky mutations that can compromise the vaccine, the study indicated.The research team also compared neutralising antibody levels following administration of one and two doses of the vaccine, as opposed to levels in patients that have recovered from Covid-19.AThe team found that vaccination provided optimal levels of protection, when compared to the lower levels of protection that were observed in recovered patients.A recent study, published in the journal Nature, also indicated that Covid-19 vaccines developed by Moderna and Pfizer-BioNTech significantly appear less effective against the Covid variant that first emerged in South Africa.IANS Jerusalem For Latest Updates Please-
Join us on
Follow us on
172.31.16.186